Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataplexy | 4 | 2017 | 25 | 1.640 |
Why?
|
| Narcolepsy | 4 | 2017 | 45 | 1.390 |
Why?
|
| Neuropeptides | 8 | 2013 | 106 | 1.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2013 | 216 | 1.090 |
Why?
|
| Neurons | 14 | 2017 | 881 | 1.000 |
Why?
|
| Orexins | 8 | 2017 | 52 | 0.990 |
Why?
|
| Enteric Nervous System | 8 | 2000 | 9 | 0.580 |
Why?
|
| Genetic Therapy | 3 | 2016 | 291 | 0.530 |
Why?
|
| Sleep | 4 | 2013 | 263 | 0.530 |
Why?
|
| Pancreas | 8 | 2001 | 225 | 0.500 |
Why?
|
| Amygdala | 1 | 2016 | 159 | 0.490 |
Why?
|
| Protein Kinase C | 1 | 2013 | 270 | 0.430 |
Why?
|
| Gene Transfer Techniques | 3 | 2013 | 173 | 0.430 |
Why?
|
| ErbB Receptors | 1 | 2013 | 239 | 0.420 |
Why?
|
| Myenteric Plexus | 4 | 2001 | 4 | 0.410 |
Why?
|
| Subthalamus | 1 | 2011 | 3 | 0.400 |
Why?
|
| Guinea Pigs | 11 | 2001 | 124 | 0.390 |
Why?
|
| Intestines | 3 | 1999 | 114 | 0.350 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2008 | 17 | 0.330 |
Why?
|
| Brain | 1 | 2017 | 2175 | 0.280 |
Why?
|
| Animals | 22 | 2017 | 20877 | 0.270 |
Why?
|
| Immunohistochemistry | 9 | 2013 | 1174 | 0.260 |
Why?
|
| Sleep, REM | 3 | 2016 | 93 | 0.250 |
Why?
|
| Neurons, Afferent | 2 | 1999 | 32 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 2550 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 2790 | 0.200 |
Why?
|
| Intestine, Small | 2 | 1999 | 89 | 0.190 |
Why?
|
| Submucous Plexus | 1 | 2000 | 1 | 0.190 |
Why?
|
| Mice | 7 | 2016 | 8472 | 0.190 |
Why?
|
| Neurotransmitter Agents | 1 | 2001 | 102 | 0.190 |
Why?
|
| Digestive System | 1 | 1999 | 35 | 0.180 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2000 | 75 | 0.180 |
Why?
|
| Intestinal Mucosa | 3 | 1997 | 219 | 0.170 |
Why?
|
| Calcium Channels | 1 | 1999 | 59 | 0.170 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2013 | 95 | 0.170 |
Why?
|
| Glutamic Acid | 3 | 2000 | 332 | 0.160 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 1997 | 59 | 0.160 |
Why?
|
| Glucose | 1 | 1999 | 307 | 0.160 |
Why?
|
| Receptors, Nicotinic | 1 | 1998 | 41 | 0.160 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 128 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 1999 | 597 | 0.140 |
Why?
|
| Rats | 8 | 2008 | 5300 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2008 | 2083 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2013 | 1199 | 0.130 |
Why?
|
| Electroencephalography | 3 | 2013 | 418 | 0.130 |
Why?
|
| Emotions | 1 | 2016 | 244 | 0.120 |
Why?
|
| Electromyography | 2 | 2013 | 184 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 337 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2013 | 12 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 80 | 0.120 |
Why?
|
| Hypothalamic Hormones | 1 | 2013 | 13 | 0.120 |
Why?
|
| Pituitary Hormones | 1 | 2013 | 16 | 0.120 |
Why?
|
| Melanins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 254 | 0.110 |
Why?
|
| Pons | 1 | 2013 | 35 | 0.110 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 2 | 2009 | 21 | 0.110 |
Why?
|
| Toxins, Biological | 2 | 2009 | 23 | 0.110 |
Why?
|
| Male | 14 | 2016 | 37281 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2013 | 1692 | 0.100 |
Why?
|
| Nerve Fibers | 3 | 2001 | 77 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2001 | 160 | 0.090 |
Why?
|
| Gastrointestinal Motility | 2 | 1999 | 52 | 0.090 |
Why?
|
| Periaqueductal Gray | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 1999 | 39 | 0.090 |
Why?
|
| Cell Line | 1 | 2013 | 1752 | 0.090 |
Why?
|
| Receptors, Serotonin | 3 | 1996 | 74 | 0.090 |
Why?
|
| Ileum | 2 | 2000 | 28 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 785 | 0.080 |
Why?
|
| Prosencephalon | 1 | 2008 | 38 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2008 | 191 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1032 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 200 | 0.080 |
Why?
|
| Reflex | 2 | 1999 | 21 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 765 | 0.080 |
Why?
|
| Adenosine | 1 | 2008 | 165 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2008 | 311 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 376 | 0.070 |
Why?
|
| Synaptic Transmission | 2 | 1999 | 236 | 0.070 |
Why?
|
| Stilbamidines | 2 | 1996 | 13 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2673 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 1999 | 1663 | 0.060 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 2001 | 19 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2000 | 87 | 0.060 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1998 | 30 | 0.050 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2001 | 1 | 0.050 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2001 | 1 | 0.050 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2001 | 3 | 0.050 |
Why?
|
| Axons | 2 | 1999 | 139 | 0.050 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2001 | 5 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1999 | 282 | 0.050 |
Why?
|
| Female | 6 | 2016 | 38015 | 0.050 |
Why?
|
| Duodenum | 1 | 2001 | 47 | 0.050 |
Why?
|
| Hexamethonium | 2 | 1997 | 4 | 0.050 |
Why?
|
| Tetrodotoxin | 2 | 1997 | 26 | 0.050 |
Why?
|
| Wakefulness | 2 | 2013 | 75 | 0.050 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2000 | 41 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 1999 | 314 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 1999 | 1 | 0.050 |
Why?
|
| Tolbutamide | 1 | 1999 | 5 | 0.050 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1999 | 2 | 0.050 |
Why?
|
| Orexin Receptors | 1 | 1999 | 11 | 0.050 |
Why?
|
| Diazoxide | 1 | 1999 | 9 | 0.050 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2000 | 51 | 0.050 |
Why?
|
| Synapses | 2 | 1999 | 222 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 1 | 1999 | 22 | 0.050 |
Why?
|
| Hunger | 1 | 1999 | 27 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1999 | 3 | 0.040 |
Why?
|
| Serotonin | 2 | 1997 | 144 | 0.040 |
Why?
|
| Potassium Channels | 1 | 1999 | 55 | 0.040 |
Why?
|
| Protein Precursors | 1 | 1999 | 105 | 0.040 |
Why?
|
| Leptin | 1 | 1999 | 80 | 0.040 |
Why?
|
| Nervous System | 1 | 1999 | 45 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 1999 | 67 | 0.040 |
Why?
|
| Colon | 1 | 1999 | 168 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 137 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 1999 | 246 | 0.040 |
Why?
|
| Humans | 2 | 2017 | 68525 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 1997 | 266 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 167 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 1998 | 22 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 710 | 0.040 |
Why?
|
| Neurotoxins | 1 | 1997 | 30 | 0.040 |
Why?
|
| Benzothiadiazines | 1 | 1997 | 4 | 0.040 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1997 | 12 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1997 | 27 | 0.040 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 21 | 0.040 |
Why?
|
| Organelles | 1 | 1997 | 18 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 1997 | 18 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 1997 | 61 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 117 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 1997 | 99 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2008 | 7028 | 0.040 |
Why?
|
| Antibodies | 1 | 1997 | 241 | 0.040 |
Why?
|
| Peptides | 1 | 1999 | 455 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 510 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1994 | 1 | 0.030 |
Why?
|
| Nicotine | 1 | 1997 | 350 | 0.030 |
Why?
|
| Delta Rhythm | 1 | 2013 | 11 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Color | 1 | 2013 | 50 | 0.030 |
Why?
|
| Calcium | 1 | 1997 | 929 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2013 | 78 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 98 | 0.030 |
Why?
|
| Membrane Potentials | 3 | 1997 | 200 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 204 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2013 | 229 | 0.030 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 218 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 1996 | 201 | 0.020 |
Why?
|
| Fluorescent Dyes | 3 | 1996 | 191 | 0.020 |
Why?
|
| Microdialysis | 1 | 2008 | 147 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2008 | 81 | 0.020 |
Why?
|
| Autoradiography | 2 | 1993 | 94 | 0.010 |
Why?
|
| Tritium | 2 | 1993 | 101 | 0.010 |
Why?
|
| Ganglia | 1 | 1997 | 6 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1997 | 16 | 0.010 |
Why?
|
| Neurites | 1 | 1997 | 18 | 0.010 |
Why?
|
| Biotin | 1 | 1997 | 28 | 0.010 |
Why?
|
| Fluoxetine | 1 | 1997 | 40 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1997 | 31 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 98 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1997 | 44 | 0.010 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1997 | 34 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 1997 | 24 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 1997 | 59 | 0.010 |
Why?
|
| Neuroglia | 1 | 1997 | 136 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 163 | 0.010 |
Why?
|
| Necrosis | 1 | 1997 | 239 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1996 | 14 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1996 | 57 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1996 | 20 | 0.010 |
Why?
|
| Colchicine | 1 | 1996 | 48 | 0.010 |
Why?
|
| Action Potentials | 1 | 1997 | 223 | 0.010 |
Why?
|
| Pyridinium Compounds | 1 | 1996 | 40 | 0.010 |
Why?
|
| Calbindins | 1 | 1996 | 23 | 0.010 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 1996 | 21 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1996 | 98 | 0.010 |
Why?
|
| Axonal Transport | 1 | 1994 | 9 | 0.010 |
Why?
|
| Amylases | 1 | 1994 | 17 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1996 | 290 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 102 | 0.010 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1993 | 9 | 0.010 |
Why?
|
| Membranes | 1 | 1993 | 26 | 0.010 |
Why?
|
| Mitochondria | 1 | 1997 | 643 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1992 | 35 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1992 | 45 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 165 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1994 | 323 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1994 | 382 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 631 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 1640 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1992 | 523 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 1039 | 0.010 |
Why?
|